Cash Flow

v3.8.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Cash flows from operating activities:    
Net income (loss) attributable to MariMed Inc. $ 122,309 $ (210,189)
Net income (loss) attributable to non-controlling interests 177,852 182,768
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Depreciation and amortization 263,624 166,108
Equity compensation 284,640 5,154
Loss on debt conversions 482,133
Unrealized trading losses, net (268)
Changes in operating assets and liabilities:    
Accounts receivable, net (793,081) (302,237)
Deferred rents receivable (71,887)
Due from third parties (467,583) (355,130)
Due from related parties 52,727 77,594
Other current assets (66,422) (180,751)
Other assets (169,990) (268)
Accounts payable and accrued expenses 3,095,297 256,035
Due to related parties (53,342) 108,477
Deferred revenue (226,950)
Other liabilities 500 (20,000)
Net cash provided by (used in) operating activities 2,629,827 (277,861)
Cash flows from investing activities:    
Purchases of fixed assets (11,502,688) (3,346,355)
Proceeds from issuance of notes receivable 29,625 16,587
Net cash used in investing activities (11,473,063) (3,329,768)
Cash flows from financing activities:    
Proceeds from subscribed preferred stock 200,000
Issuance of common stock 5,150,000 206,157
Issuance of promissory notes 3,650,000 2,867,592
Proceeds from (paydown of) mortgage payable (80,622) 892,810
Exercise of stock options 7,500
Distributions (301,749)
Net cash provided by financing activities 8,926,878 3,664,810
Net change to cash and cash equivalents 83,642 57,181
Cash and cash equivalents at beginning of period 569,356 160,859
Cash and cash equivalents at end of period 652,998 218,040
Supplemental disclosure of cash flow information:    
Cash paid for interest 418,738 158,489
Cash paid for taxes 8,138
Non-cash activities:    
Equity issued to convert debt $ 2,050,000

Source